HOME> お知らせ> ATCC®ウェビナーのお知らせ
(Antimicrobial Resistanceについて:全2回)

ATCC®ウェビナーのお知らせ
(Antimicrobial Resistanceについて:全2回)

掲載日情報:2020/02/17 現在Webページ番号:68691

ATCC®(メーカー略称:ACC)では 2020年2月14日,28日に無料のウェビナーを開催しました。是非ご覧いただき,皆様の今後のご研究にお役立て下さい。

第1回

・演題:Antimicrobial Resistance: A Broad-spectrum Public Health Crisis
・演者:Christine Fedorchuk, Ph.D., Senior Biologist, ATCC
・言語:英語
・開催日:2020年2月14日(金)2:00 am(日本時間)

ウェビナーの詳細,録画版はこちら

ATCCウェビナーの詳細ページ

Abstract:

The first modern mainstream antibiotic, penicillin, was introduced for common use in 1942. Reports of penicillin resistance began with Staphylococcus aureus isolated in hospitals- in 1942. In 2019, over 2.8 million cases of antimicrobial-resistant (AMR) infections were reported by the CDC in the United States alone, making it a serious global health threat, and prevalence is steadily rising. Our understanding of the AMR phenomenon is constantly advancing and evolving our knowledge of how resistance mechanisms work, what causes drug resistance, how it spreads, and who is affected. This two-part webinar highlights the growing global threat caused by AMR infections. In part one of this webinar, we will provide an overview of drug resistance mechanisms, their spread, and current knowledge about the global impact of AMR infections.

Key Takeaways:

  • Understanding the true burden of antimicrobial resistant infections: explaining the global prevalence and epidemiology of drug-resistant infections, breaking down morbidity and mortality of the most critical pathogens, and underlining the unsustainable toll that AMR infections take.
  • Explaining how drug resistance works: demonstrating how antibiotics and other antimicrobial compounds work, the molecular mechanisms employed by AMR pathogens to evade these drugs, and how resistance continues to spread.

目次に戻る

第2回

・演題:Antimicrobial Resistance: Arm Your Lab in the Fight Against Superbugs
・演者:Christine Fedorchuk, Ph.D., Senior Biologist, ATCC®
・言語:英語
・開催日:2020年2月28日(金)2:00 am(日本時間)

ウェビナーの詳細,録画版はこちら

ATCCウェビナーの詳細ページ

Abstract:

The first modern mainstream antibiotic, penicillin, was introduced for common use in 1942. Reports of penicillin resistance began with Staphylococcus aureus isolated in hospitals- in 1942. In 2019, over 2.8 million cases of antimicrobial-resistant (AMR) infections were reported by the CDC in the United States alone, making it a serious global health threat, and prevalence is steadily rising. Our understanding of the AMR phenomenon is constantly advancing, evolving our knowledge of how resistance mechanisms work, what causes drug resistance, how it spreads, and who is affected. This two-part webinar highlights the growing global threat caused by AMR infections. In part two of this webinar, we will provide an overview of the biggest challenges facing the field, progress in diagnosis, research, and development; and further information. We will also show how ATCC is addressing this challenge through its pledge to support global health by developing and improving collections of high-quality biological materials for use in research, diagnostics, drug and product development, and clinical applications.

Key Takeaways:

  • Understanding the nature of the problem: explaining the biggest challenges hindering advancement such as financial deficits, implementation of surveillance or new therapies, and the speed of resistance outpacing the speed of scientific research.
  • Explaining progress: scientific and clinical advances, how organizations are contributing to the fight against AMR, and how ATCC is contributing to the fight against AMR.


© 2020 American Type Culture Collection. The ATCC trademark and trade name, and any other trademarks listed in this publication are trademarks owned by the American Type Culture Collection unless indicated otherwise.

目次に戻る

製品情報は掲載時点のものですが、価格表内の価格については随時最新のものに更新されます。お問い合わせいただくタイミングにより製品情報・価格などは変更されている場合があります。
表示価格に、消費税等は含まれていません。一部価格が予告なく変更される場合がありますので、あらかじめご了承下さい。